These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36986567)

  • 1. Amphiphilic Cell-Penetrating Peptides Containing Arginine and Hydrophobic Residues as Protein Delivery Agents.
    Moreno J; Zoghebi K; Salehi D; Kim L; Shoushtari SK; Tiwari RK; Parang K
    Pharmaceuticals (Basel); 2023 Mar; 16(3):. PubMed ID: 36986567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphiphilic Cell-Penetrating Peptides Containing Natural and Unnatural Amino Acids as Drug Delivery Agents.
    Salehi D; Mozaffari S; Zoghebi K; Lohan S; Mandal D; Tiwari RK; Parang K
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclic and Linear Peptides Containing Alternate WW and RR Residues as Molecular Cargo Delivery Tools.
    Kim L; Lohan S; Moreno J; Zoghebi K; Tiwari RK; Parang K
    Mol Pharm; 2023 Jan; 20(1):341-356. PubMed ID: 36445335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hybrid Cyclic-Linear Cell-Penetrating Peptides Containing Alternative Positively Charged and Hydrophobic Residues as Molecular Transporters.
    Khayyatnejad Shoushtari S; Zoghebi K; Sajid MI; Tiwari RK; Parang K
    Mol Pharm; 2021 Oct; 18(10):3909-3919. PubMed ID: 34491768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [(WR)
    Zoghebi K; Aliabadi HM; Tiwari RK; Parang K
    Cells; 2022 Jan; 11(2):. PubMed ID: 35053417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphiphilic Peptides for Efficient siRNA Delivery.
    Mozaffari S; Bousoik E; Amirrad F; Lamboy R; Coyle M; Hall R; Alasmari A; Mahdipoor P; Parang K; Montazeri Aliabadi H
    Polymers (Basel); 2019 Apr; 11(4):. PubMed ID: 30999603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Molecular Transporter Properties of Cyclic Peptides Containing Tryptophan and Arginine Residues Formed through Disulfide Cyclization.
    Mohammed EHM; Mandal D; Mozaffari S; Abdel-Hamied Zahran M; Mostafa Osman A; Kumar Tiwari R; Parang K
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32498339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic Peptide-Gadolinium Nanocomplexes as siRNA Delivery Tools.
    Nasrolahi Shirazi A; Sajid MI; Mandal D; Stickley D; Nagasawa S; Long J; Lohan S; Parang K; Tiwari RK
    Pharmaceuticals (Basel); 2021 Oct; 14(11):. PubMed ID: 34832846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Molecular Transporter Efficiency of Cyclic Peptides Containing Tryptophan and Arginine Residues.
    Hanna SE; Mozaffari S; Tiwari RK; Parang K
    ACS Omega; 2018 Nov; 3(11):16281-16291. PubMed ID: 31458264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient delivery of cell impermeable phosphopeptides by a cyclic peptide amphiphile containing tryptophan and arginine.
    Nasrolahi Shirazi A; Tiwari RK; Oh D; Banerjee A; Yadav A; Parang K
    Mol Pharm; 2013 May; 10(5):2008-20. PubMed ID: 23537165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic Peptides as Protein Kinase Inhibitors: Structure-Activity Relationship and Molecular Modeling.
    Sanner MF; Zoghebi K; Hanna S; Mozaffari S; Rahighi S; Tiwari RK; Parang K
    J Chem Inf Model; 2021 Jun; 61(6):3015-3026. PubMed ID: 34000187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient Intracellular Delivery of Cell-Impermeable Cargo Molecules by Peptides Containing Tryptophan and Histidine.
    Shirazi AN; Mozaffari S; Sherpa RT; Tiwari R; Parang K
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29949881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, Synthesis, and Evaluation of Oleyl-WRH Peptides for siRNA Delivery.
    Rai MS; Sajid MI; Moreno J; Parang K; Tiwari RK
    Pharmaceuticals (Basel); 2024 Aug; 17(8):. PubMed ID: 39204188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and application of hybrid cyclic-linear peptide-doxorubicin conjugates as a strategy to overcome doxorubicin resistance and toxicity.
    Mozaffari S; Salehi D; Mahdipoor P; Beuttler R; Tiwari R; Aliabadi HM; Parang K
    Eur J Med Chem; 2021 Dec; 226():113836. PubMed ID: 34537446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antiproliferative activities of doxorubicin thiol conjugates and doxorubicin-SS-cyclic peptide.
    Darwish S; Sadeghiani N; Fong S; Mozaffari S; Hamidi P; Withana T; Yang S; Tiwari RK; Parang K
    Eur J Med Chem; 2019 Jan; 161():594-606. PubMed ID: 30396106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic Peptide Containing Hydrophobic and Positively Charged Residues as a Drug Delivery System for Curcumin.
    Shirazi AN; El-Sayed NS; Tiwari RK; Tavakoli K; Parang K
    Curr Drug Deliv; 2016; 13(3):409-17. PubMed ID: 26511089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced cellular uptake of short polyarginine peptides through fatty acylation and cyclization.
    Oh D; Nasrolahi Shirazi A; Northup K; Sullivan B; Tiwari RK; Bisoffi M; Parang K
    Mol Pharm; 2014 Aug; 11(8):2845-54. PubMed ID: 24978295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic peptide-capped gold nanoparticles as drug delivery systems.
    Nasrolahi Shirazi A; Mandal D; Tiwari RK; Guo L; Lu W; Parang K
    Mol Pharm; 2013 Feb; 10(2):500-11. PubMed ID: 22998473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and biological evaluation of cell-penetrating peptide-doxorubicin conjugates as prodrugs.
    Nasrolahi Shirazi A; Tiwari R; Chhikara BS; Mandal D; Parang K
    Mol Pharm; 2013 Feb; 10(2):488-99. PubMed ID: 23301519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphiphilic bicyclic peptides as cellular delivery agents.
    Oh D; Darwish SA; Shirazi AN; Tiwari RK; Parang K
    ChemMedChem; 2014 Nov; 9(11):2449-53. PubMed ID: 25047914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.